Abstract
Pyrazolealdehydes (4a–d), Knoevenagel’s condensates (5a–d) and Schiff’s bases (6a–d) of curcumin-I were synthesized, purified and characterized. Hemolysis assays, cell line activities, DNA bindings and docking studies were carried out. These compounds were lesser hemolytic than standard drug doxorubicin. Minimum cell viability (MCF-7; wild) observed was 59% (1.0μg/mL) whereas the DNA binding constants ranged from 1.4×103 to 8.1×105M−1. The docking energies varied from −7.30 to −13.4kcal/mol. It has been observed that DNA-compound adducts were stabilized by three governing forces (Van der Wall’s, H-bonding and electrostatic attractions). It has also been observed that compounds 4a–d preferred to enter minor groove while 5a–d and 6a–d interacted with major grooves of DNA. The anticancer activities of the reported compounds might be due to their interactions with DNA. These results indicated the bright future of the reported compounds as anticancer agents.